Annual Accounts Payable:
$12.91M-$2.83M(-17.98%)Summary
- As of today, TXG annual accounts payable is $12.91 million, with the most recent change of -$2.83 million (-17.98%) on December 31, 2024.
- During the last 3 years, TXG annual accounts payable has fallen by -$4.44 million (-25.60%).
- TXG annual accounts payable is now -40.23% below its all-time high of $21.60 million, reached on December 31, 2022.
Performance
TXG Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Payable:
$18.07M+$2.13M(+13.37%)Summary
- As of today, TXG quarterly accounts payable is $18.07 million, with the most recent change of +$2.13 million (+13.37%) on September 30, 2025.
- Over the past year, TXG quarterly accounts payable has dropped by -$8.14 million (-31.06%).
- TXG quarterly accounts payable is now -96.60% below its all-time high of $531.18 million, reached on December 1, 2014.
Performance
TXG Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TXG Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -18.0% | -31.1% |
| 3Y3 Years | -25.6% | -16.3% |
| 5Y5 Years | -0.9% | +90.4% |
TXG Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -40.2% | at low | -38.4% | +79.5% |
| 5Y | 5-Year | -40.2% | +174.1% | -38.4% | +283.7% |
| All-Time | All-Time | -40.2% | +174.1% | -96.6% | +283.7% |
TXG Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $18.07M(+13.4%) |
| Jun 2025 | - | $15.94M(+58.3%) |
| Mar 2025 | - | $10.07M(-22.0%) |
| Dec 2024 | $12.91M(-18.0%) | $12.91M(-50.7%) |
| Sep 2024 | - | $26.21M(+23.4%) |
| Jun 2024 | - | $21.25M(+5.1%) |
| Mar 2024 | - | $20.22M(+28.5%) |
| Dec 2023 | $15.74M(-27.1%) | $15.74M(-16.4%) |
| Sep 2023 | - | $18.84M(-18.5%) |
| Jun 2023 | - | $23.12M(-21.1%) |
| Mar 2023 | - | $29.32M(+35.7%) |
| Dec 2022 | $21.60M(+24.5%) | $21.60M(+0.0%) |
| Sep 2022 | - | $21.59M(-19.2%) |
| Jun 2022 | - | $26.73M(+41.0%) |
| Mar 2022 | - | $18.96M(+9.3%) |
| Dec 2021 | $17.35M(+268.5%) | $17.35M(+1.8%) |
| Sep 2021 | - | $17.04M(+5.3%) |
| Jun 2021 | - | $16.18M(+3.9%) |
| Mar 2021 | - | $15.58M(+230.8%) |
| Dec 2020 | $4.71M | $4.71M(-50.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $9.49M(-4.3%) |
| Jun 2020 | - | $9.92M(-26.6%) |
| Mar 2020 | - | $13.51M(+3.7%) |
| Dec 2019 | $13.03M(+48.2%) | $13.03M(+8.9%) |
| Sep 2019 | - | $11.96M(+26.8%) |
| Jun 2019 | - | $9.43M(+7.2%) |
| Dec 2018 | $8.79M(+61.5%) | $8.79M(+61.5%) |
| Dec 2017 | $5.44M | - |
| Dec 2017 | - | $5.44M(-97.5%) |
| Sep 2017 | - | $220.81M(+12.6%) |
| Jun 2017 | - | $196.14M(-0.3%) |
| Mar 2017 | - | $196.78M(-1.2%) |
| Dec 2016 | - | $199.08M(+24.1%) |
| Sep 2016 | - | $160.43M(-8.3%) |
| Jun 2016 | - | $174.86M(-4.9%) |
| Mar 2016 | - | $183.85M(-9.5%) |
| Dec 2015 | - | $203.13M(-44.3%) |
| Sep 2015 | - | $364.48M(-20.0%) |
| Jun 2015 | - | $455.75M(+14.7%) |
| Mar 2015 | - | $397.45M(-25.2%) |
| Dec 2014 | - | $531.18M |
FAQ
- What is 10x Genomics, Inc. annual accounts payable?
- What is the all-time high annual accounts payable for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. annual accounts payable year-on-year change?
- What is 10x Genomics, Inc. quarterly accounts payable?
- What is the all-time high quarterly accounts payable for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. quarterly accounts payable year-on-year change?
What is 10x Genomics, Inc. annual accounts payable?
The current annual accounts payable of TXG is $12.91M
What is the all-time high annual accounts payable for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high annual accounts payable is $21.60M
What is 10x Genomics, Inc. annual accounts payable year-on-year change?
Over the past year, TXG annual accounts payable has changed by -$2.83M (-17.98%)
What is 10x Genomics, Inc. quarterly accounts payable?
The current quarterly accounts payable of TXG is $18.07M
What is the all-time high quarterly accounts payable for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high quarterly accounts payable is $531.18M
What is 10x Genomics, Inc. quarterly accounts payable year-on-year change?
Over the past year, TXG quarterly accounts payable has changed by -$8.14M (-31.06%)